Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma is a devastating disease. There are roughly 20-25,000 new cases per year in the United States and it is increasing for some reason.

12 Feb 2013

PharmaJet receives Performance, Quality and Safety pre-qualified certification from WHO

PharmaJet Inc. has become the first and only needle-free injection company to receive Performance, Quality and Safety (PQS) pre-qualified certification from the World Health Organization (WHO).

12 Feb 2013

RNF20 protein required for MLL-rearranged leukemia amplification

Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics.

12 Feb 2013

Individualized flu immune responses revealed by high-throughput sequencing

Researchers have shown that it is possible to create personalized, individual-specific measurements of the antibody repertoire in response to influenza vaccination using high-throughput DNA sequencing technology.

11 Feb 2013

'Urgent need’ for primary care pneumonia diagnosis tools

While family doctors can exclude pneumonia with a high level of accuracy, they can only identify around a third of radiographically confirmed cases, research shows.

11 Feb 2013

Wichita State associate professor writes two books about flu

The flu: It's a popular topic of conversation lately, as most people probably know someone who has gotten sick this winter. But for Wichita State associate professor George Dehner, the flu is a year-round focus. Dehner, who teaches world and environmental history, recently wrote two books about the flu.

11 Feb 2013

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

Biogen Idec and Swedish Orphan Biovitrum (Sobi) released data that confirmed the ability of investigational recombinant factors VIII Fc fusion protein (rFVIIIFc) and IX Fc fusion protein (rFIXFc) to provide long-lasting protection from bleeding with fewer injections than are required with the current standard of care for people with hemophilia.

10 Feb 2013

Global response to possible H5N1 flu outbreak could affect epidemic's course

"It's been a rough flu season this winter in the United States and Europe, but it could be worse. A lot worse," science writer Carl Zimmer states in National Geographic's "Phenomena: The Loom" blog.

10 Feb 2013

Roundup: Assisted suicide legalization urged; Abortion bill tensions in Wash., Ore.; Budget squeezes in Ga., Conn.

A push for the legalization of physician-assisted suicide is under way in a half-dozen states where proponents say they see strong support for allowing doctors to prescribe mentally competent, dying individuals with the medications needed to end their own lives. ... Groups such as Compassion & Choices, a national end-of-life advocacy organization, have been working to advance the cause.

10 Feb 2013

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

10 Feb 2013

Northwestern Medicine to open new Outpatient Center in Glenview, Illinois

Northwestern Medicine today announced that on March 1 it will open a new Outpatient Center at 2701 Patriot Boulevard in Glenview, Illinois. At this new center, 20-30 physicians will offer patients a wide range of primary care and specialty clinical services.

10 Feb 2013

Social networking sites could effectively help prevent HIV infection among at-risk groups

Facebook and other social networking technologies could serve as effective tools for preventing HIV infection among at-risk groups, new UCLA research suggests.

9 Feb 2013

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

Deadly flu viruses, including the H5N1 bird flu and H3N2 swine flu, may have met their match in FluGen's universal vaccine, REDEE FLU.

6 Feb 2013

AmeriCares rushes to deliver 8,000 more doses of influenza vaccine to free clinics

AmeriCares is rushing to deliver 8,000 more doses of influenza vaccine to free clinics and community health programs to stem the continuing flu epidemic. Widespread flu activity was reported last week in 42 states with seniors at the greatest risk, according to the latest data from the Centers for Disease Control and Prevention. While the number of flu cases is starting to decline along the East Coast, cases continue to increase in the West.

6 Feb 2013

ZOLL's Intravascular Temperature Management solution receives Shonin approval in Japan

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature Management (IVTM) technology—the first intravascular temperature management system to receive Shonin approval in Japan.

6 Feb 2013

Three NIH-sponsored influenza trials begin to enroll volunteers

Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at several dozen other domestic and international sites.

6 Feb 2013

Viewpoints: Sen. Hatch's prescription for safeguarding entitlements; Medicare crackdown on CVS drug program; JFK's mental health vision failing

American families are used to working with dollar amounts starting with hundreds and thousands. But the fiscal situation of our country requires us to act in terms of billions and trillions. ... Unfortunately, waiting until the last minute to stop a crisis has become standard operating procedure in Washington. But that isn't how we should be tackling our debt or safeguarding Medicare and Medicaid.

5 Feb 2013

Injection-free vaccination technique shows promise

Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.

5 Feb 2013

‘Urgent need’ for primary care pneumonia diagnosis tools

While family doctors can exclude pneumonia with a high level of accuracy, they can only identify around a third of radiographically confirmed cases, research shows.

5 Feb 2013

BD first quarter revenues increase 3.7% to $1.90 billion

BD, a leading global medical technology company, today reported quarterly revenues of $1.90 billion for the first fiscal quarter ended December 31, 2012, representing an increase of 3.7 percent from the prior-year period, or 5.2 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 5 Feb 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

PharmaJet receives Performance, Quality and Safety pre-qualified certification from WHO

RNF20 protein required for MLL-rearranged leukemia amplification

Individualized flu immune responses revealed by high-throughput sequencing

'Urgent need’ for primary care pneumonia diagnosis tools

Wichita State associate professor writes two books about flu

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

Global response to possible H5N1 flu outbreak could affect epidemic's course

Roundup: Assisted suicide legalization urged; Abortion bill tensions in Wash., Ore.; Budget squeezes in Ga., Conn.

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Northwestern Medicine to open new Outpatient Center in Glenview, Illinois

Social networking sites could effectively help prevent HIV infection among at-risk groups

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

AmeriCares rushes to deliver 8,000 more doses of influenza vaccine to free clinics

ZOLL's Intravascular Temperature Management solution receives Shonin approval in Japan

Three NIH-sponsored influenza trials begin to enroll volunteers

Viewpoints: Sen. Hatch's prescription for safeguarding entitlements; Medicare crackdown on CVS drug program; JFK's mental health vision failing

Injection-free vaccination technique shows promise

‘Urgent need’ for primary care pneumonia diagnosis tools

BD first quarter revenues increase 3.7% to $1.90 billion

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in